The major risk factors for hepatocellular carcinoma (HCC) in contemporary clinical practice
are becoming increasingly related to sustained virological response after hepatitis C …

Hepatocellular carcinoma (HCC) is the most frequent liver neoplasm, and its incidence rates
are constantly increasing. Despite the availability of potentially curative treatments (liver …

Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is a
leading cause of cancer-related death worldwide. In the United States, HCC is the ninth …

Liver transplantation for hepatocellular carcinoma (HCC) is the best treatment option for
patients with early-stage tumours and accounts for∼ 20–40% of all liver transplantations …

Hepatocellular carcinoma (HCC) is among the leading causes of cancer-related mortality.
The principal treatment is surgical resection or liver transplantation, depending on whether …

The selection of liver transplant candidates with hepatocellular carcinoma (HCC) relies
mostly on tumor size and number. Instead of relying on these factors, we used poor tumor …

Hepatocellular carcinoma (HCC) is a heterogeneous disease that remains highly prevalent
in many Asian countries and is the second most common cause of cancer‐related mortality …

We recently identified a histological subtype of hepatocellular carcinoma (HCC), designated
as “macrotrabecular‐massive”(MTM‐HCC) and associated with specific molecular features …

Liver transplantation (LT) is a highly successful treatment for many patients with
nonmalignant and malignant liver diseases. However, there is a worldwide shortage of …

Hepatocellular carcinoma (HCC) is rapidly becoming one of the most prevalent cancers
worldwide. With a rising rate, it is a prominent source of mortality. Patients with advanced …